Skip to main content
Vireo Growth Inc. logo

Vireo Growth Inc. — Investor Relations & Filings

Ticker · VREO ISIN · CA38238W1032 CSE Manufacturing
Open in API
Filings indexed 543 across all filing types
Latest filing 2021-04-05 Regulatory Filings
Country CA Canada
Listing CSE VREO

About Vireo Growth Inc.

https://vireogrowth.com/

Vireo Growth Inc. is a science-focused cannabis company that cultivates, processes, and distributes medical and adult-use cannabis products. The company emphasizes environmentally friendly cultivation practices, often utilizing greenhouses, and manufactures pharmaceutical-grade cannabis extracts. Vireo Growth operates wholesale and retail business lines, selling its portfolio of branded products through company-owned dispensaries and distribution networks. The company's mission is to provide safe access, quality products, and value to its customers, coupled with a commitment to community support and restorative justice programs.

Recent filings

Filing Released Lang Actions
52-109F1 - Certification of annual filings - CEO (E).pdf
Regulatory Filings Classification · 95% confidence The document is a certification pursuant to SEC rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. It is signed by the CEO and certifies the accuracy and completeness of the Annual Report on Form 10-K for Vireo Health International, Inc. The text does not contain actual financial data or the full annual report but is a formal officer certification related to the 10-K report. According to the Certification Rule, such documents should be classified as Regulatory Filings (RNS) rather than the Annual Report (10-K) itself.
2021-04-05 English
52-109F1 - Certification of annual filings - CFO (E).pdf
Regulatory Filings Classification · 100% confidence The document is a certification pursuant to SEC rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. It is signed by the CFO and certifies the accuracy and completeness of the Annual Report on Form 10-K for Vireo Health International, Inc. The document does not contain actual financial data or the full report but is an officer certification related to the 10-K report. According to the Certification Rule, such certifications should be classified as Regulatory Filings (RNS), not as the Annual Report itself.
2021-04-05 English
Annual MD&A - English.pdf
Regulatory Filings Classification · 90% confidence The document contains only references to omitted pictures and no textual content or financial data. The length is very short (934 characters) and there is no indication of any report content, financial statements, or announcements. Given the lack of substantive text and the presence of only images, this does not qualify as a report or detailed filing. It is likely a placeholder or a presentation with images only, but without further context, it best fits the fallback category for miscellaneous filings that do not fit other categories.
2021-04-05 English
ON form 13-502F1 (class 1 and 3B reporting issuers - participation fee).pdf
Regulatory Filings Classification · 95% confidence The document is a Management Certification related to Form 13-502F1, which is a regulatory form submitted to the Ontario Securities Commission concerning participation fees for reporting issuers. It contains certification by an officer of the company about the completeness and accuracy of the information provided. The content is primarily a certification letter and fee calculation details, not a full financial report or detailed management discussion. It does not contain financial statements or substantive financial data typical of annual or interim reports. It is not an announcement of a report but a regulatory filing with certification. Therefore, it fits best under Regulatory Filings (RNS).
2021-04-05 English
AB form 13-501F1 (class 1 and 3B reporting issuers - participation fee).pdf
Regulatory Filings Classification · 100% confidence The document is a Form 13-501F1 titled 'Class 1 Reporting Issuers and Class 3B Reporting Issuers – Participation Fee' with a management certification by an officer of the reporting issuer. It contains detailed calculations of market values of securities for specified trading periods and the resulting participation fee payable. The document is a regulatory form submitted to the Alberta Securities Commission, primarily consisting of certification and fee calculation rather than financial statements or management discussion. It is not an annual or interim report, nor an earnings release or investor presentation. It is a regulatory filing related to compliance and fee payment. Therefore, it fits best under Regulatory Filings (RNS).
2021-04-05 English
Audited annual financial statements – English.pdf
Audit Report / Information Classification · 95% confidence The document is a detailed audit report from Davidson & Company LLP, an independent registered public accounting firm, addressed to the shareholders and directors of Vireo Health International, Inc. It includes an opinion on the consolidated financial statements for the years ended December 31, 2020 and 2019, and contains detailed financial statements such as balance sheets, notes, and disclosures. The presence of an auditor's opinion, detailed financial data, and notes indicates this is a standalone audit report rather than a full annual report or a brief announcement. The document length (15,000 characters) and content confirm it is not a short announcement or certification. Therefore, the appropriate classification is Audit Report / Information (AR). FY 2020
2021-04-05 English

Browse filings by year

19 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.